Patents Assigned to Ivantis, Inc.
-
Patent number: 11197779Abstract: An ocular implant including an intraocular pressure sensor and having an inlet portion and a Schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the Schlemm's canal portion being arranged and configured to be disposed within Schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.Type: GrantFiled: August 12, 2016Date of Patent: December 14, 2021Assignee: IVANTIS, INC.Inventors: David Theodore Van Meter, Kenneth M. Galt
-
Patent number: 11026836Abstract: An ocular implant adapted to be disposed within Schlemm's canal of a human eye with a body extending along a curved longitudinal central axis in a curvature plane, a first strut on one side of the implant and a second strut on an opposite side of the implant, the circumferential extent of the first strut with respect to the plane of curvature being greater than the circumferential extent of the second strut with respect to the plane of curvature. The invention also includes methods of using the implant.Type: GrantFiled: May 9, 2016Date of Patent: June 8, 2021Assignee: IVANTIS, INC.Inventors: John Wardle, Andrew T. Schieber
-
Publication number: 20210030590Abstract: An ocular implant including a drug releasing element and having an inlet portion and a Schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the Schlemm's canal portion being arranged and configured to be disposed within Schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.Type: ApplicationFiled: February 19, 2019Publication date: February 4, 2021Applicant: Ivantis, Inc.Inventors: Wendy Blanda, Rhett Schiffman
-
Patent number: 10709547Abstract: A method and system for deploying an ocular implant into Schlemm's canal of an eye. The method includes the steps of inserting a distal end of a cannula through a cornea of the eye and into an anterior chamber of the eye, the cannula having a distal opening extending from the distal end and through a side wall, a curved distal portion and a curved intermediate portion; placing the distal opening of the cannula into fluid communication with Schlemm's canal; advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the cannula distal opening.Type: GrantFiled: July 14, 2015Date of Patent: July 14, 2020Assignee: IVANTIS, INC.Inventor: Andrew T. Schieber
-
Patent number: 10687978Abstract: An apparatus having an inserter device with a shaft disposed in an interior space and an intraocular implant adapted to self-retain to an inner wall of Schlemm's canal. The intraocular implant has a proximal portion sized and shaped to reside within an anterior chamber of the eye, the proximal portion having a proximal opening; a distal portion sized and shaped to reside within Schlemm's canal of the eye, the distal portion having a distal opening, and a passageway extending in a straight line from the proximal opening to the distal opening to conduct fluid from the anterior chamber to Schlemm's canal. The shaft of the inserter device is adapted to advance the intraocular implant out of the interior space and through an inner wall of Schlemm's canal.Type: GrantFiled: July 29, 2019Date of Patent: June 23, 2020Assignee: IVANTIS, INC.Inventor: Michael S. Berlin
-
Patent number: 10617558Abstract: An ocular implant adapted to be disposed within Schlemm's canal of a human eye with a body extending along a curved longitudinal central axis in a curvature plane, a first strut on one side of the implant and a second strut on an opposite side of the implant, the circumferential extent of the first strut with respect to the plane of curvature being greater than the circumferential extent of the second strut with respect to the plane of curvature. The invention also includes methods of using the implant.Type: GrantFiled: November 26, 2013Date of Patent: April 14, 2020Assignee: IVANTIS, INC.Inventors: Andrew T. Schieber, Iqbal K. Ahmed
-
Patent number: 10537474Abstract: An ocular implant for treating glaucoma is provided, which may include any number of features. More particularly, the present invention relates to implants that facilitate the transfer of fluid from within one area of the eye to another area of the eye. One feature of the implant is that it includes a proximal inlet portion and a distal inlet portion adapted to be inserted into the anterior chamber of the eye, and an intermediate portion adapted to be inserted into Schlemm's canal. Another feature of the implant is that it can be biased to assume a predetermined shape to aid in placement within the eye.Type: GrantFiled: May 22, 2017Date of Patent: January 21, 2020Assignee: IVANTIS, INC.Inventors: Charles L. Euteneuer, Thomas R. Hektner, Andrew T. Schieber, John Wardle
-
Patent number: 10492949Abstract: An ocular implant delivery system is provided with a number of features. In some embodiments, the delivery system comprises a rotation mechanism configured to rotate and orient a cannula of the system, and an advancement mechanism configured to advance and retract an ocular implant through the delivery system and into an eye of a patient. In some embodiments, the cannula is sized and configured to be inserted into Schlemm's canal of the eye. The ocular implant is configured to maintain its orientation within the delivery system as the cannula is rotated. In some embodiments, the ocular implant automatically disengages the delivery system when it is advanced beyond a distal tip of the delivery system. Methods of implanting an ocular implant are also provided.Type: GrantFiled: June 23, 2017Date of Patent: December 3, 2019Assignee: IVANTIS, INC.Inventors: John Wardle, Andrew T. Schieber
-
Patent number: 10406025Abstract: An ocular implant is provided. In some embodiments, the ocular implant includes a body that is curved about a longitudinal central axis and a distal body portion that defines a longitudinal channel including a channel opening. The implant is sized and configured such that the ocular implant assumes an orientation in which the channel opening is adjacent a major side of Schlemm's canal when the ocular implant is disposed in Schlemm's canal. Methods for delivering ocular implants into Schlemm's canal are also provided. Some methods include covering openings in the ocular implant, advancing the implant into Schlemm's canal while at least some of the openings are covered, and uncovering the openings while the distal portion of the implant is disposed in Schlemm's canal.Type: GrantFiled: November 4, 2015Date of Patent: September 10, 2019Assignee: IVANTIS, INC.Inventors: John Wardle, Andrew T. Schieber, Kenneth M. Galt
-
Patent number: 10390993Abstract: An apparatus having an inserter device with a shaft disposed in an interior space and an intraocular implant adapted to self-retain to an inner wall of Schlemm's canal. The intraocular implant has a proximal portion sized and shaped to reside within an anterior chamber of the eye, the proximal portion having a proximal opening; a distal portion sized and shaped to reside within Schlemm's canal of the eye, the distal portion having a distal opening, and a passageway extending in a straight line from the proximal opening to the distal opening to conduct fluid from the anterior chamber to Schlemm's canal. The shaft of the inserter device is adapted to advance the intraocular implant out of the interior space and through an inner wall of Schlemm's canal.Type: GrantFiled: May 6, 2019Date of Patent: August 27, 2019Assignee: IVANTIS, INC.Inventor: Michael S. Berlin
-
Patent number: 10363168Abstract: An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. The implant includes a spine extending along a longitudinal axis of the implant, a plurality of curved supports extending from the spine, each support comprising a first end extending from a first location on a first side of the spine and a second end extending from a second location on a second side of the spine, the second location being proximal to the first location, so that each support forms a portion of a helix, the spine and supports defining a volume having a maximum width perpendicular to the longitudinal axis between 0.005 inches and 0.04 inches, the ocular implant being configured to bend preferentially in a preferential bending plane.Type: GrantFiled: September 2, 2015Date of Patent: July 30, 2019Assignee: IVANTIS, INC.Inventors: Andrew T. Schieber, Kenneth M. Galt
-
Patent number: 10335314Abstract: An apparatus having an inserter device with a shaft disposed in an interior space and an intraocular implant adapted to self-retain to an inner wall of Schlemm's canal. The intraocular implant has a proximal portion sized and shaped to reside within an anterior chamber of the eye, the proximal portion having a proximal opening; a distal portion sized and shaped to reside within Schlemm's canal of the eye, the distal portion having a distal opening, and a passageway extending in a straight line from the proximal opening to the distal opening to conduct fluid from the anterior chamber to Schlemm's canal. The shaft of the inserter device is adapted to advance the intraocular implant out of the interior space and through an inner wall of Schlemm's canal.Type: GrantFiled: November 20, 2018Date of Patent: July 2, 2019Assignee: IVANTIS, INC.Inventor: Michael S. Berlin
-
Patent number: 10159601Abstract: A method and delivery system are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for reducing elevated intraocular pressure. Pulsed laser radiation is delivered from the distal end of a fiber-optic probe sufficient to cause photoablation of selected portions of the trabecular meshwork, the juxtacanalicular trabecular meshwork and an inner wall of Schlemm's canal in the target site. The fiber-optic probe may be advanced so as to create an aperture in the inner wall of Schlemm's canal in which fluid from the anterior chamber of the eye flows. The method and delivery system may further be used on any tissue types in the body.Type: GrantFiled: November 9, 2017Date of Patent: December 25, 2018Assignee: IVANTIS, INC.Inventor: Michael S. Berlin
-
Patent number: 9931243Abstract: A method of deploying an ocular implant into Schlemm's canal of an eye. The method includes the steps of inserting a distal end of a cannula through a cornea of the eye and into an anterior chamber of the eye, the cannula having a distal opening extending from the distal end and through a side wall; placing the distal opening of the cannula into fluid communication with Schlemm's canal; advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the cannula distal opening. The invention also includes a system for practicing the method.Type: GrantFiled: January 8, 2015Date of Patent: April 3, 2018Assignee: IVANTIS, INC.Inventors: John Wardle, Andrew T. Schieber
-
Publication number: 20170360609Abstract: An ocular implant having an inlet portion and a Schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the Schlemm's canal portion being arranged and configured to be disposed within Schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.Type: ApplicationFiled: February 1, 2016Publication date: December 21, 2017Applicant: IVANTIS, INC.Inventors: Andrew T. SCHIEBER, Charles L. EUTENEUER
-
Patent number: 9693902Abstract: An ocular implant for treating glaucoma is provided, which may include any number of features. More particularly, the present invention relates to implants that facilitate the transfer of fluid from within one area of the eye to another area of the eye. One feature of the implant is that it includes a proximal inlet portion and a distal inlet portion adapted to be inserted into the anterior chamber of the eye, and an intermediate portion adapted to be inserted into Schlemm's canal. Another feature of the implant is that it can be biased to assume a predetermined shape to aid in placement within the eye.Type: GrantFiled: May 20, 2015Date of Patent: July 4, 2017Assignee: IVANTIS, INC.Inventors: Charles L. Euteneuer, Thomas R. Hektner, Andrew T. Schieber, John Wardle
-
Patent number: 9693899Abstract: An ocular implant delivery system is provided with a number of features. In some embodiments, the delivery system comprises a rotation mechanism configured to rotate and orient a cannula of the system, and an advancement mechanism configured to advance and retract an ocular implant through the delivery system and into an eye of a patient. In some embodiments, the cannula is sized and configured to be inserted into Schlemm's canal of the eye. The ocular implant is configured to maintain its orientation within the delivery system as the cannula is rotated. In some embodiments, the ocular implant automatically disengages the delivery system when it is advanced beyond a distal tip of the delivery system. Methods of implanting an ocular implant are also provided.Type: GrantFiled: July 9, 2010Date of Patent: July 4, 2017Assignee: IVANTIS, INC.Inventors: John Wardle, Andrew T. Schieber
-
Patent number: 9610196Abstract: An ocular implant having an inlet portion and a Schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the Schlemm's canal portion being arranged and configured to be disposed within Schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.Type: GrantFiled: April 20, 2015Date of Patent: April 4, 2017Assignee: IVANTIS, INC.Inventors: Andrew T. Schieber, Charles L. Euteneuer
-
Patent number: 9579234Abstract: A method of treating glaucoma in a human eye by inserting a distal exit port of a cannula at least partially into Schlemm's canal of the eye; delivering a dye through the cannula into Schlemm's canal; identifying obstructions within Schlemm's canal; and delivering an ocular implant through the cannula into Schlemm's canal.Type: GrantFiled: May 16, 2014Date of Patent: February 28, 2017Assignee: IVANTIS, INC.Inventors: John Wardle, Andrew T. Schieber, Kenneth M. Galt
-
Patent number: 9510973Abstract: An ocular implant is provided that is adapted to reside at least partially in a portion of Schlemm's canal of an eye. The implant includes an implant body having plurality of filars extending along a longitudinal axis of the implant. The implant is configured to move between a radially collapsed state and a radially expanded state. In some embodiments, the implant is configured to assume the radially expanded state when no external forces are acting thereon. Methods of delivering and using the ocular implant are also provided.Type: GrantFiled: June 23, 2011Date of Patent: December 6, 2016Assignee: IVANTIS, INC.Inventor: John Wardle